نتائج البحث - "Paulette A. Lyle"

1

دورية أكاديمية

Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study

المؤلفون: Darcy A. Hille, Paulette A. Lyle, Peter M. Okin, Björn Dahlöf, Suzanne Oparil, Ingrid Os, Veronica Franco, Sverre E. Kjeldsen, Karin Manhem, Richard B. Devereux, Left Ventricular Hypertrophy, Eva Gerdts

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://hyper.ahajournals.org/content/51/4/1103.full.pdfTest.

وصف الملف: application/pdf

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.519.8480Test; http://hyper.ahajournals.org/content/51/4/1103.full.pdfTest

الإتاحة: http://hyper.ahajournals.org/content/51/4/1103.full.pdfTest

View record in BASE

2

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study

المؤلفون: Frej Fyhrquist, Kåre Berg, Paulette A. Lyle, Ulf de Faire, Børge G. Nordestgaard, Darcy A. Hille, Marianne Benn, Hans Ibsen, Mia Sandberg, Kimmo Kontula, Ingrid Os, Peggy H. Wong, Erik Eliasson, Björn Dahlöf, Amar A. Sethi, Jonathan M. Edelman

المصدر: Pharmacogenetics and Genomics. 20:77-85

مصطلحات موضوعية: Male, medicine.medical_specialty, Angiotensin receptor, Genotype, Endpoint Determination, Blood Pressure, Peptidyl-Dipeptidase A, Left ventricular hypertrophy, Losartan, law.invention, Muscle hypertrophy, INDEL Mutation, Randomized controlled trial, Heart Rate, law, Internal medicine, Genetics, Humans, Medicine, cardiovascular diseases, General Pharmacology, Toxicology and Pharmaceutics, Molecular Biology, Antihypertensive Agents, Genetics (clinical), Aged, Aged, 80 and over, Polymorphism, Genetic, business.industry, Middle Aged, medicine.disease, Atenolol, Treatment Outcome, Endocrinology, Blood pressure, Hypertension, cardiovascular system, Cardiology, Molecular Medicine, Female, Hypertrophy, Left Ventricular, business, hormones, hormone substitutes, and hormone antagonists, Pharmacogenetics, circulatory and respiratory physiology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff42b4e849b3ddc4707ce6d9e15a6db0Test
https://doi.org/10.1097/fpc.0b013e328333f70bTest

3

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

المؤلفون: Hans Ibsen, Gareth Beevers, Giovanni de Simone, Per Omvik, Hans Wedel, Ulf de Faire, Kristian Wachtell, Richard B. Devereux, Björn Dahlöf, Suzanne Oparil, Markku S. Nieminen, Frej Fyhrquist, Sverre E. Kjeldsen, Lars H Lindholm, Ole Lederballe-Pedersen, Michael H. Olsen, Paulette A. Lyle

المصدر: Journal of Hypertension. 27:567-574

مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Physiology, Diastole, Blood Pressure, Left ventricular hypertrophy, Losartan, Muscle hypertrophy, Electrocardiography, chemistry.chemical_compound, Internal medicine, Internal Medicine, Humans, Multicenter Studies as Topic, Medicine, Antihypertensive Agents, Aged, Randomized Controlled Trials as Topic, Dose-Response Relationship, Drug, medicine.diagnostic_test, business.industry, Cholesterol, Cholesterol, HDL, Middle Aged, Lipid Metabolism, medicine.disease, Atenolol, Angiotensin II, Treatment Outcome, Endocrinology, chemistry, Cardiovascular Diseases, Hypertension, Cardiology, Female, Hypertrophy, Left Ventricular, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb83053a037231fac28f464538ae08fTest
https://doi.org/10.1097/hjh.0b013e32831daf96Test

4

Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy

المؤلفون: Veronica Franco, Darcy A. Hille, Peter M. Okin, Paulette A. Lyle, Björn Dahlöf, Karin Manhem, Ingrid Os, Eva Gerdts, Richard B. Devereux, Suzanne Oparil, Sverre E. Kjeldsen

المصدر: Hypertension. 51:1103-1108

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955284f1675d8bfdd19f2a5d1a36bebcTest
https://doi.org/10.1161/hypertensionaha.107.105296Test

5

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy

المؤلفون: Dick de Zeeuw, Paulette A. Lyle, Jared Lunceford, Mark E. Cooper, Peter Rossing, Peggy H. Wong, Barry M. Brenner, Shahnaz Shahinfar, Hans-Henrik Parving, Giuseppe Remuzzi, Nancy Liu

المساهمون: Groningen Kidney Center (GKC)

المصدر: Journal of the American Society of Nephrology, 19(4), 771-779. AMER SOC NEPHROLOGY

مصطلحات موضوعية: Male, INSERTION/DELETION POLYMORPHISM, medicine.medical_specialty, CHRONIC PROTEINURIC NEPHROPATHIES, DD-GENOTYPE, Urology, DELETION POLYMORPHISM, PROGRESSION, Peptidyl-Dipeptidase A, CONTROLLED-TRIAL, Losartan, Nephropathy, chemistry.chemical_compound, ANGIOTENSIN-I, Clinical Research, Diabetes mellitus, Internal medicine, medicine, Clinical endpoint, Humans, Diabetic Nephropathies, Creatinine, CONVERTING-ENZYME GENE, Polymorphism, Genetic, biology, business.industry, STAGE RENAL-DISEASE, Angiotensin-converting enzyme, General Medicine, Middle Aged, medicine.disease, Angiotensin II, Endocrinology, Diabetes Mellitus, Type 2, chemistry, PROSPECTIVE COHORT, Nephrology, biology.protein, Female, business, Angiotensin II Type 1 Receptor Blockers, medicine.drug, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09f461b8caaff9a0693bddedb91f400Test
https://research.rug.nl/en/publications/be6b68cc-b0c9-47d7-bab2-5bf95e69c72aTest

6

A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension

المؤلفون: James L. Pool, Erluo Chen, A. Lerman, Stevo Julius, Mark A. Creager, Vincent A. Galet, Gang Jia, Nicola Abate, Andrew M. Tershakovec, Suzanne Oparil, Paulette A. Lyle

المصدر: Current Medical Research and Opinion. 24:1101-1114

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0993e3e6916ded549f9e58b7a04889Test
https://doi.org/10.1185/030079908x280716Test

7

Effect of Hemoglobin Levels on Cardiovascular Outcomes in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy (from the LIFE Study)

المؤلفون: Darcy A. Hille, Michael H. Olsen, Marianne Lislerud Smebye, Aud Høieggen, Björn Dahlöf, Arnljot Flaa, Emil K. Iversen, Paulette A. Lyle, Ingrid Os, Sverre E. Kjeldsen, Arghya Chattopadhyay, Richard B. Devereux

المصدر: The American Journal of Cardiology. 100:855-859

مصطلحات موضوعية: Male, medicine.medical_specialty, Systolic hypertension, Adrenergic beta-Antagonists, Population, Left ventricular hypertrophy, Losartan, Electrocardiography, Hemoglobins, Double-Blind Method, Cause of Death, Internal medicine, medicine, Humans, Prospective Studies, cardiovascular diseases, education, Antihypertensive Agents, Aged, Cause of death, Aged, 80 and over, education.field_of_study, Framingham Risk Score, business.industry, Hazard ratio, Middle Aged, medicine.disease, Atenolol, Stroke, Cardiovascular Diseases, Heart failure, Hypertension, Cardiology, Female, Hypertrophy, Left Ventricular, Cardiology and Cardiovascular Medicine, business, Angiotensin II Type 1 Receptor Blockers, Follow-Up Studies, Glomerular Filtration Rate, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beeb86ab7feae71825414a9a988a359eTest
https://doi.org/10.1016/j.amjcard.2007.03.109Test

8

The effect of angiotensin receptor blockers for preventing atrial fibrillation

المؤلفون: Richard B. Devereux, Kristian Wachtell, Paulette A. Lyle

المصدر: Current Hypertension Reports. 9:278-283

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d5f96e990daf2c545971f43b24f666Test
https://doi.org/10.1007/s11906-007-0051-1Test

9

Atenolol as a comparator in outcome trials in hypertension: A correct choice in the past, but not for the future?

المؤلفون: Björn Dahlöf, Sverre E. Kjeldsen, Jonathan M. Edelman, Zhongxin Zhang, Richard B. Devereux, Paulette A. Lyle

المصدر: Blood Pressure. 16:6-12

مصطلحات موضوعية: medicine.medical_specialty, Endpoint Determination, medicine.drug_class, Adrenergic beta-Antagonists, Treatment outcome, Blood Pressure, Reference Values, Internal medicine, Internal Medicine, Humans, Medicine, cardiovascular diseases, Beta blocker, Randomized Controlled Trials as Topic, Clinical Trials as Topic, business.industry, General Medicine, Calcium Channel Blockers, Atenolol, Control Groups, Treatment Outcome, Losartan, Cardiovascular Diseases, Anesthesia, Reference values, Hypertension, Practice Guidelines as Topic, cardiovascular system, Cardiology, Cardiology and Cardiovascular Medicine, business, Angiotensin II Type 1 Receptor Blockers, Cardiovascular outcomes, hormones, hormone substitutes, and hormone antagonists, circulatory and respiratory physiology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe407d241692c01a928634ed6a97abaTest
https://doi.org/10.1080/08037050701246386Test

10

A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension

المؤلفون: Paulette A. Lyle, Peter U. Feig, Gilbert W. Gleim, Joseph Rubino, Hongyan Zhang, Beth Soffer, Shahnaz Shahinfar, Thomas W. Littlejohn

المصدر: Clinical Therapeutics. 28:1639-1648

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d23cfbfb39c51179d8455c314975a39Test
https://doi.org/10.1016/j.clinthera.2006.10.014Test

تنقيح النتائج